Genmab completes patient recruitment in ofatumumab pivotal CLL study
Saturday, July 11, 2009 11:00 IST Copenhagen, Denmark
Genmab A/S has completed recruitment of patients in the pivotal study of Arzerra (ofatumumab) in the treatment of refractory chronic lymphocytic leukaemia (CLL).
